Relmada Therapeutics, Inc. RLMD Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits Percentage

Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits Percentage at other companies

Alto Ingredients, Inc.ALTO

-6.6%—

Trex CompanyTREX

0%—

Capital City Bank GroupCCBG

0.1%0.0pp

SolarEdge TechnologiesSEDG

-1.2%—

Alto Ingredients, Inc.ALTO

-6.6%—

Relmada Therapeutics, Inc.RLMD

0%—

Operating income-$19.5M-6.8%

Net income-$19.1M-8.5%

EPS (diluted)-$0.22+62.1%

Cash & equivalents$9.8M+750%

Total debt$104.1M-40.4%

Total equity$218.7M+875%

Total assets$235.4M+750%

Operating cash flow-$15.1M+16.6%

Market cap$677.17M+2,907%

Return on equity-48.8%-20.0pp

Debt / equity0.9×0.0×

Current ratio18.3×+13.0×

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlmd:EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefitsPercentage.

The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Relmada Therapeutics, Inc.'s effective income tax rate reconciliation changes in unrecognized tax benefits percentage?: Relmada Therapeutics, Inc. (RLMD) reported effective income tax rate reconciliation changes in unrecognized tax benefits percentage of 0% in Q4 2025.
What does effective income tax rate reconciliation changes in unrecognized tax benefits percentage mean?: This reflects the percentage change in the effective tax rate resulting from adjustments to unrecognized tax benefits. It provides insight into the company's management of tax positions and potential tax contingencies.